31 results
Thumbnail

D2.33 - Complex occupational allergic contact dermatitis: polysensitization in a worker exposed to metals, adhesives, and plastics

Thumbnail

D2.34 - Pediatric allergic contact cheilitis associated with propolis sensitization

Thumbnail

D2.35 - Occupational Protein Contact Dermatitis to Latex Compromising Fitness for Work in a Nurse

Thumbnail

D2.37 - Occupational Allergic Dermatoses of the Face: Allergen Distribution and Work-Related Outcomes

Thumbnail

D2.38 - Occupational Exposure to Propolis: A Rare Cause of Allergic Contact Dermatitis in Textile Workers

Thumbnail

D2.39 - Occupational Contact Dermatitis with Polysensitization to Metals: Challenges for Work Fitness and Prevention

Thumbnail

D2.40 - Occupational allergic contact dermatitis to metals: clinical features and impact on work fitness

Thumbnail

D2.41 - Production of recombinant Cuc ma 5: A Step Towards Molecular Diagnosis of Pumpkin Seed Allergy

Thumbnail

D2.42 - Evaluation of User Experience with a Skin Prick Automated Test (SPAT) Device compared to a Manual Skin Prick Test (SPT) in Pediatric Patients

Thumbnail

D2.30 - A Case of Kimura’s Disease with Atypical Presentation and Novel Genetic Findings

Thumbnail

D2.31 - A Case of Acquired C1 Inhibitor Deficiency Angioedema with Anti-C1q Antibodies in Systemic Lupus Erythematosus and Negative Exome Sequencing

Thumbnail

D2.32 - A Positive Drug Challenge to Amoxicillin and Clavulanate (AMX) in a Child, Six Years After the Initial Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE)

Thumbnail

D2.449 - Patients with Inadequately Controlled CRSwNP and Blood Eosinophil Count ≥150 cells/µL Experience Benefit with Depemokimab: An Analysis of Data from the Integrated ANCHOR-1/-2 Studies

Thumbnail

D2.447 - Phenotyping of Chronic T2 Inflammatory Diseases of the Nose and Paranasal Sinuses and the Algorithm for Biologic Therapy Selection

Thumbnail

D2.448 - Recommendations on Patient Education for Biological Therapy in CRSwNP – An EAACI Position Paper

Thumbnail

D2.450 - EUFOREA/EPOS Criteria Applied to a Diverse CRSwNP Cohort: Post Hoc Findings from Twice-Yearly depemokimab ANCHOR-1/-2 trials

Thumbnail

D2.451 - Real-life upper and lower airway outcomes of long-term dupilumab treatment in patients with severe chronic rhinosinusitis with nasal polyps

Thumbnail

D2.452 - Real-World Trends in the Epidemiology and Burden of Chronic Rhinosinusitis with Nasal Polyps Over Time in Germany Reveal Increasing Prevalence and Low Biologic Use

Thumbnail

D2.453 - Olfactory outcomes of dupilumab in patients with CRSwNP: A real-world prospective study

Thumbnail

D2.455 - Does Biological Therapy Modify NSAID Hypersensitivity? Experience with Omalizumab and Mepolizumab in Patients with Asthma and Nasal Polyps with N-ERD